ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstracts tagged "Autoinflammatory diseases"

  • Abstract Number: 1689 • ACR Convergence 2022

    Oral Ginger Supplementation Counteracts NETosis in Autoimmune Mouse Models and in Healthy Humans

    Ramadan Ali1, Miela Zahavi2, Christine Rysenga1, Cyrus Sarosh3, Claire Hoy1, Kristen Demoruelle4 and Jason S Knight5, 1University of Michigan, Ann Arbor, MI, 2Universtiy of Michigan, Ann Arbor, MI, 3University of Michigan, Temperance, MI, 4University of Colorado Anschutz Medical Campus, Aurora, CO, 5University of Michigan, Division of Rheumatology, Ann Arbor, MI

    Background/Purpose: It has previously been reported that 6-gingerol, the most abundant phytochemical in ginger root, inhibits neutrophil phosphodiesterase activity and thereby counteracts neutrophil hyperactivity in…
  • Abstract Number: 1943 • ACR Convergence 2022

    Prevalence and Evolution of Undifferentiated Periodic Fever Syndromes in an Academic Pediatric Rheumatology Practice

    Jacob Anderson1, Catherine Bingham2, Lisabeth Scalzi3, Natalya Gaffney4, Kimberly Hays5, Brandt Groh2 and Timothy Hahn2, 1Phoenix Children's Hospital, Phoenix, AZ, 2Penn State Children's Hospital, Hershey, PA, 3Penn State Health, Hummelstown, PA, 4Self-Employed, Carlisle, PA, 5Penn State Health, Hershey, PA

    Background/Purpose: Periodic Fever Syndromes (PFS) are common referrals to pediatric rheumatology clinics. While the syndrome of Periodic Fevers, Aphthous stomatitis, Pharyngitis, and Adenitis (PFAPA) is…
  • Abstract Number: 0134 • ACR Convergence 2022

    Combination Treatment with Baricitinib and Pulse Steroids in Severe COVID19: A

    Francesco Ferro1, Elena Elefante2, Italiano Nazzareno2, Gaetano La Rocca3, Davide Schilirò2, Michele Moretti2, Roberto Mozzo4, De Simone Luigi4, Chiara Baldini5 and Marta Mosca2, 1Clinical and Experimental Medicine Department, Azienda Ospedaliero-Universitaria Pisana, Pisa, Pisa, Italy, 2University of Pisa, Pisa, Italy, 3University of Pisa, Rheumatology Unit, Palermo, Palermo, Italy, 4Anesthesiology & Intensive Care Unit/Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy, 5University of Pisa, Pisa, Pisa, Italy

    Background/Purpose: Growing evidence from RCTs and real-life experiences has highlighted important similarities between severe COVID19 and rapidly progressive interstitial lung diseases (RP-ILD) occurring in connective…
  • Abstract Number: 0812 • ACR Convergence 2022

    3-years Safety and Efficacy Outcomes of Canakinumab Treatment in Cryopyrin-associated Periodic Syndromes (CAPS) – Data from the RELIANCE Registry

    Jasmin B. Kuemmerle-Deschner1, Birgit Kortus-Goetze2, Prasad T. Oommen3, Ales Janda4, Juergen Rech5, Catharina Schuetz6, Tilmann Kallinich7, Frank Weller-Heinemann8, Gerd Horneff9, Ivan Foeldvari10, Florian Meier11, Michael Borte12, Tobias Krickau13, Julia Weber-Arden14 and Norbert Blank15, 1Department of Pediatrics, Division of Pediatric Rheumatology, University Hospital Tübingen, Tübingen, Germany, 2Division of Nephrology, University of Marburg, Marburg, Germany, 3Clinic of Pediatric Hematology, Oncology and Clinical Immunology, Heinrich-Heine-University Duesseldorf, Duesseldorf, Germany, 4Department of Pediatrics, University Hospital Ulm, Ulm, Germany, 5University Clinic Erlangen, Erlangen, Germany, 6Pediatrics, Medizinische Fakultaet Carl Gustav Carus, Technische Universitaet Dresden, Dresden, Germany, 7Charité - Universitätsmedizin Berlin, Nuremberg, Germany, 8Klinikum Bremen-Mitte, Prof. Hess Kinderklinik, Bremen, Germany, 9Pediatrics, Asklepios Klinik Sankt Augustin GmbH, Sankt Augustin, Germany, 10Hamburger Zentrum für Kinder- und Jugendrheumatologie, Hamburg, Germany, 11Division of Rheumatology, University Hospital Frankfurt, Goethe University, Frankfurt am Main, Germany, and Fraunhofer Institute for Molecular Biology and Applied Ecology IME, Project Group Translational Medicine and Pharmacology TMP, Frankfurt, Germany, 12ImmunoDeficiencyCenter Leipzig (IDCL), Hospital St. Georg gGmbH Leipzig, Germany, Leipzig, Sachsen, Germany, 13Friedrich-Alexander Universität Erlangen-Nürnberg (FAU), Pediatrics, Erlangen, Germany, 14Novartis Pharma GmbH, Nuernberg, Germany, 15Rheumatology, University Hospital Heidelberg, Heidelberg, Germany

    Background/Purpose: Cryopyrin-associated periodic syndromes (CAPS) are monogenic autoinflammatory diseases with severe systemic inflammation. The IL-1β inhibitor canakinumab (CAN) leads to a rapid remission of CAPS…
  • Abstract Number: 1698 • ACR Convergence 2022

    LINE1 Reverse Transcriptase Inhibitors Abrogate Type 1 Interferon Responses

    Daniel Rios1, Nafeeza Hafeez1, Brian Desrosiers1, Shradha Rao1, Jess Floro1, Joelle Baddour1, Nisha Perez2, Greg Bisacchi2, Oliver Saunders2, Donna Romero1, Menachem Fromer2, Enrique Garcia-Rivera2, Wilson McKerrow2, Julie Behr2, Bryan Thornlow2, Dennis Zaller2, David Proia2 and Wenyan Miao2, 1Rome Therapeutics, Cambridge, MA, 2Rome Tx, Cambridge, MA

    Background/Purpose: Transposable elements (TEs) are mobile DNA elements that can replicate and move from one position to another within the host genome. Through co-evolution, TEs…
  • Abstract Number: 2101 • ACR Convergence 2022

    Outcomes of Autoimmune Hemolytic Anemia in Patients with Systemic Lupus Erythematosus: A Nationwide Inpatient Sample Study

    Ekrem Turk, Vaishali Deenadayalan, Khaldun Obeidat and Pierre Rodriguez, John H. Stroger, Jr. Hospital of Cook County, Chicago, IL

    Background/Purpose: Autoimmune Hemolytic Anemia (AIHA) is one of the manifestations of Systemic lupus erythematosus (SLE), an autoimmune connective tissue disease. AIHA may be present in…
  • Abstract Number: 0138 • ACR Convergence 2022

    Patients with Familial Mediterranean Fever (FMF) Under Canakinumab Treatment – Long-term Efficacy and Safety Interim Data of the RELIANCE Registry

    Joerg Henes1, Jasmin B. Kuemmerle-Deschner2, Tobias Krickau3, Tilmann Kallinich4, Frank Dressler5, Gerd Horneff6, Florian Meier7, Ivan Foeldvari8, Frank Weller-Heinemann9, Birgit Kortus-Goetze10, Markus Hufnagel11, Juergen Rech12, Prasad T. Oommen13, Julia Weber-Arden14 and Norbert Blank15, 1Center for Interdisciplinary Clinical Immunology, Rheumatology and Auto-inflammatory Diseases (INDIRA), University Hospital Tübingen, Tübingen, Germany, 2Department of Pediatrics, Division of Pediatric Rheumatology, University Hospital Tübingen, Tübingen, Germany, 3Friedrich-Alexander Universität Erlangen-Nürnberg (FAU), Pediatrics, Erlangen, Germany, 4Charité - Universitätsmedizin Berlin, Nuremberg, Germany, 5Division of Pediatric Pneumology, Allergology and Neonatology, Hannover Medical School, Hannover, Germany, 6Pediatrics, Asklepios Klinik Sankt Augustin GmbH, Sankt Augustin, Germany, 7Division of Rheumatology, University Hospital Frankfurt, Goethe University, Frankfurt am Main, Germany, and Fraunhofer Institute for Molecular Biology and Applied Ecology IME, Project Group Translational Medicine and Pharmacology TMP, Frankfurt, Germany, 8Hamburger Zentrum für Kinder- und Jugendrheumatologie, Hamburg, Germany, 9Klinikum Bremen-Mitte, Prof. Hess Kinderklinik, Bremen, Germany, 10Division of Nephrology, University of Marburg, Marburg, Germany, 11Division of Pediatric Infectious Diseases and Rheumatology, Department of Pediatrics and Adolescent Medicine, University Hospital Medical Center Freiburg, Medical Faculty, University of Freiburg, Freiburg, Germany, 12University Clinic Erlangen, Erlangen, Germany, 13Clinic of Pediatric Hematology, Oncology and Clinical Immunology, Heinrich-Heine-University Duesseldorf, Duesseldorf, Germany, 14Novartis Pharma GmbH, Nuernberg, Germany, 15Rheumatology, University Hospital Heidelberg, Heidelberg, Germany

    Background/Purpose: Familial Mediterranean fever (FMF) is a chronic disease characterized by recurrent episodes of fever and serositis, with a risk of severe complications (e. g.…
  • Abstract Number: 0813 • ACR Convergence 2022

    Canakinumab in Patients with Tumor Necrosis Factor Receptor-associated Periodic Syndrome (TRAPS) – Long-term Efficacy and Safety Data from a RELIANCE Registry Interim Analysis

    Norbert Blank1, Catharina Schuetz2, Joerg Henes3, Tilmann Kallinich4, Prasad T. Oommen5, Michael Borte6, Markus Hufnagel7, Ales Janda8, Julia Weber-Arden9 and Jasmin B. Kuemmerle-Deschner10, 1Rheumatology, University Hospital Heidelberg, Heidelberg, Germany, 2Pediatrics, Medizinische Fakultaet Carl Gustav Carus, Technische Universitaet Dresden, Dresden, Germany, 3Center for Interdisciplinary Clinical Immunology, Rheumatology and Auto-inflammatory Diseases (INDIRA), University Hospital Tübingen, Tübingen, Germany, 4Charité - Universitätsmedizin Berlin, Nuremberg, Germany, 5Clinic of Pediatric Hematology, Oncology and Clinical Immunology, Heinrich-Heine-University Duesseldorf, Duesseldorf, Germany, 6ImmunoDeficiencyCenter Leipzig (IDCL), Hospital St. Georg gGmbH Leipzig, Germany, Leipzig, Sachsen, Germany, 7Division of Pediatric Infectious Diseases and Rheumatology, Department of Pediatrics and Adolescent Medicine, University Hospital Medical Center Freiburg, Medical Faculty, University of Freiburg, Freiburg, Germany, 8Department of Pediatrics, University Hospital Ulm, Ulm, Germany, 9Novartis Pharma GmbH, Nuernberg, Germany, 10Department of Pediatrics, Division of Pediatric Rheumatology, University Hospital Tübingen, Tübingen, Germany

    Background/Purpose: TRAPS is a rare hereditary autoinflammatory disease characterized by periodic fever and severe systemic and organ inflammation. Successful treatment was achieved with the interleukin-1β…
  • Abstract Number: 1701 • ACR Convergence 2022

    High TNFAIP3-Transfected Cell Activity: An In Vitro Model for Phagocyte Study of Monogenic Behçet’s Disease Pathophysiology

    Patricia Pontes Aires1, André Cunha1, DANIELA GERENT PETRY PIOTTO1, Maria Teresa Terreri2 and Sandro Perazzio1, 1Universidade Federal de São Paulo, São Paulo, Brazil, 2Universidad Federal São Paulo, São Paulo, Brazil

    Background/Purpose: A20 haploinsufficiency (A20HA), an important monogenic etiology of Behçet's disease (BD), is caused by loss-of-function mutations in TNFAIP3. Although monocytes play an important role…
  • Abstract Number: 2194 • ACR Convergence 2022

    Is Vaccination Against Covid-19 Associated with Autoimmune Rheumatic Disease Flare? Self-controlled Case Series Analysis Using Data from the Clinical Practice Research Datalink (Aurum)

    Georgina Nakafero1, Matthew J. Grainge1, Tim Card1, Christian Mallen2, Jonathan S. Nguyen van Tam1, Hywel C. Williams1 and Abhishek Abhishek1, 1University of Nottingham, Nottingham, United Kingdom, 2Keele University, Keele, United Kingdom

    Background/Purpose: It is unclear whether autoimmune rheumatic disease (AIRD) flares are associated with the recent prior Covid-19 vaccination, and whether the association was influenced by…
  • Abstract Number: 0139 • ACR Convergence 2022

    A Clinical Study Designed to Support a Demonstration of Interchangeability Between AVT02 and Reference Adalimumab (Humira®)

    Steven Feldman1, Heimo stroissnig2, Richard Kay3, Joanna Sobierska4, Roshan Dias4, Eric Guenzi5, Hendrik Otto2, Halimuniyazi Haliduola2, Abid Sattar6, Ruth Ruffieux4, Matjaz Steijger4 and Fausto Berti4, 1Wake Forest School of Medicine, Winston-Salem, NC, 2Alvotech, Jülich, Germany, 3RK Statistics, Bakewell, United Kingdom, 4Alvotech, Zürich, Switzerland, 5UGA Biopharma, Bonn, Germany, 6Alvotech, London, United Kingdom

    Background/Purpose: To support a demonstration of interchangeability of proposed biosimilar AVT02 and Humira® (reference adalimumab).Methods: Participants with chronic plaque psoriasis were selected for the study…
  • Abstract Number: 0815 • ACR Convergence 2022

    Hyper-IgG4 in Patients with Systemic Autoinflammatory Disease

    Brianne Navetta-Modrov and QingPing Yao, Stony Brook University, Stony Brook, NY

    Background/Purpose: Hyper-immunoglobulin G4 (IgG4) has been reported in various conditions including autoimmune disease, gastrointestinal disorders, lymphoproliferative/granulomatous diseases and solid tumors. IgG4-related disease is an immune-mediated…
  • Abstract Number: 1721 • ACR Convergence 2022

    Protective Effects of the Natural Antioxidant Taxifolin in Models of Lupus and Antiphospholipid Syndrome

    Christine Rysenga1, Linda May-Zhang2, Miela Zahavi3, Jason S Knight4 and Ramadan Ali1, 1University of Michigan, Ann Arbor, MI, 2Blue California, Rancho Santa Margarita, CA, 3Universtiy of Michigan, Ann Arbor, MI, 4University of Michigan, Division of Rheumatology, Ann Arbor, MI

    Background/Purpose: Taxifolin, also known as dihydroquercetin, is a bioactive flavonoid commonly found in apples, onions, French maritime bark, and milk thistle. Given its potent anti-inflammatory…
  • Abstract Number: 2209 • ACR Convergence 2022

    Efficacy of Secukinumab in Enthesitis-related Arthritis and Juvenile Psoriatic Arthritis Subtypes of Juvenile Idiopathic Arthritis: Results from a Randomized, Phase 3 Study

    Hermine Brunner1, Elena Chertok2, Joke Dehoorne3, Gerd Horneff4, Tilmann Kallinich5, Ingrid Louw6, Maria Alessio7, Sandrine Compeyrot-Lacassagne8, Bernard Lauwerys9, Neil Martin10, Katherine Marzan11, W Patrick Knibbe12, Ruvie Martin13, Xuan Zhu14, sarah whelan15, Luminita Pricop16, Daniel Lovell17, Alberto Martini18 and Nicola Ruperto19, 1Division of Rheumatology, Cincinnati Children's Hospital Medical Center, University of Cincinnati, Department of Pediatrics, Cincinnati, OH, 2Voronezh State Medical University, Voronezh, Russia, 3University Hospital Gent, Gent, Belgium, 4Pediatrics, Asklepios Klinik Sankt Augustin GmbH, Sankt Augustin, Germany, 5Charité - Universitätsmedizin Berlin, Nuremberg, Germany, 6Panaroma Medical Centre, Cape Town, South Africa, 7Policlinico Federico II di Napoli, Napoli, Italy, 8Great Ormond Street Hospital for Children, London, United Kingdom, 9Cliniques Universitaires Saint-Luc, Brussels, Belgium, 10Royal Hospital for Children, Glasgow, Scotland, United Kingdom, 11Children's Hospital Los Angeles, Los Angeles, CA, 12St. Luke's Hospital System, Meridian, ID, 13Novartis Pharmaceutical Corporation, East Hanover, NJ, 14Novartis Pharmaceuticals Corporation, Basking Ridge, NJ, 15Novartis Ireland Ltd, Crumlin, Dublin, Ireland, 16Novartis Pharmaceuticals Corporation, East Hanover, NJ, 17Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 18Istituto Giannina Gaslini, Genova, Italy, 19IRCCS Istituto Giannina Gaslini; PRINTO, Clinica Pediatrica e Reumatologia, Genova, Italy

    Background/Purpose: Juvenile idiopathic arthritis (JIA) categories of enthesitis-related arthritis (ERA) and juvenile psoriatic arthritis (JPsA) represent pediatric counterparts of adult non-radiographic axial spondyloarthritis and psoriatic…
  • Abstract Number: 0142 • ACR Convergence 2022

    A Systemic Autoinflammatory Syndrome Caused by NEMO Exon 5 Skipping

    Bin Lin1, Adriana Almeida de Jesus2, Eric Karlins1, Dana Kahle1, Sophia Park3, Andre Rastegar1, Jacob Mitchell4, sofia Torregiani1, Farzana Bhuyan5, Sara Alehashemi6, Kader Cetin Gedik7, Kat Uss8, Eric Hanson9, Amer Khojah10, Eveline Wu11, Christiaan Scott12, Timothy Ronan Leahy13, Emma J. MacDermott13, Orla G. Killeen13, Chyi-Chia Richard Lee14, Thaschawee Arkachaisri15, Zoran Gucev16, Kathryn Cook17, Vafa Mammadova18, Gulnara Nasrullayeva18, Mariana Correia Marques19, Abigail Bosk20, Seza Ozen21, Abigail Lang22, Brian Nolan23, Scott Canna24, Maude Tusseau25, Emilie Chopin25, Guilaine Boursier26, Danielle Fink27, Douglas Kuhns27, Clifton Dalgard28, Alexandre Belot29, Timothy Moran30, Andrew Oler3 and Raphaela Goldbach-Mansky31, 1NIH, Bethesda, MD, 2NIAID, NIH, Silver Spring, MD, 3NIAID, Bethesda, MD, 4NIAID NIH, Bethesda, MD, 5National Institutes of Health, Bethesda, MD, 6NIH/NIAID/TADS, Clarksville, MD, 7Translational Autoinflammatory Diseases Section (TADS)/NIAID/NIH, Bethesda, MD, 8National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, 9Indiana University School of Medicine, Indianapolis, IN, 10Umm Al-Qura University, Makkah, Saudi Arabia, 11University of North Carolina, Chapel Hill, NC, 12University of Cape Town, Red Cross War Memorial Children's Hospital, Cape Town, South Africa, 13CHI at Crumlin, Dublin, Ireland, 14National Cancer Institute, National Institutes of Health, Bethesda, MD, 15KK Women's and Children's Hospital, SingHealth, Singapore, Singapore, 16University Children's Hospital, Medical Faculty Skopje, Skopje, Macedonia, 17Akron Children's Hospital, Akron, OH, 18Azerbaijan Medical University, Baku, Azerbaijan, 19National Institute of Arthritis and Musculoskeletal and Skin Diseases / Children`s National Hospital, Bethesda, MD, 20Children's National Hospital, Washington, DC, 21Hacettepe University Faculty of Medicine, Ankara, Turkey, 22Lurie Children's Hospital, Chicago, IL, 23Ann & Robert H. Lurie Children's Hospital, Chicago, IL, 24Children's Hospital of Philadelphia, Philadelphia, PA, 25Service de Néphrologie, Rhumatologie, Dermatologie Pédiatriques, Centre de Référence des Rhumatismes Inflammatoires et Maladies Auto-Immunes Rares de l'Enfant (RAISE), Hôpital Femme-Mère-Enfant, Hospices Civils de Lyon, Bron, France, 26Laboratoire de Génétique des Maladies Rares et Autoinflammatoires, Département de Génétique Médicale, Maladies Rares et Médecine Personnalisée, CEREMAIA, CHU de Montpellier, Univ Montpellier, Montpellier, France, 27National Institute of Allergy and Infectious Diseases, National Institutes of Health, Frederick, MD, 28The American Genome Center, Uniformed Services University of the Health Sciences, Bethesda, MD, 29Hospices Civils de Lyon, Collonges au mont d'or, France, 30University of North Carolina School of Medicine, Chapel Hill, NC, 31NIH/NIAID, Potomac, MD

    Background/Purpose: NF-kB essential modulator (NEMO, encoded by IKBKG) is an essential gene in immune response, development, and cell death regulation. Mutations in NEMO have been…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 10
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

© COPYRIGHT 2023 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences